Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia.
Clin Cancer Res. 2017 Jun 1;23(11):2831-2841. doi: 10.1158/1078-0432.CCR-16-0463. Epub 2016 Nov 30.
Clin Cancer Res. 2017.
PMID: 27903679
Free PMC article.
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse Model.
Niemann CU, Mora-Jensen HI, Dadashian EL, Krantz F, Covey T, Chen SS, Chiorazzi N, Izumi R, Ulrich R, Lannutti BJ, Wiestner A, Herman SEM.
Niemann CU, et al. Among authors: krantz f.
Clin Cancer Res. 2017 Oct 1;23(19):5814-5823. doi: 10.1158/1078-0432.CCR-17-0650. Epub 2017 Jun 23.
Clin Cancer Res. 2017.
PMID: 28645939
Free PMC article.
Item in Clipboard
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.
Barf T, Covey T, Izumi R, van de Kar B, Gulrajani M, van Lith B, van Hoek M, de Zwart E, Mittag D, Demont D, Verkaik S, Krantz F, Pearson PG, Ulrich R, Kaptein A.
Barf T, et al. Among authors: krantz f.
J Pharmacol Exp Ther. 2017 Nov;363(2):240-252. doi: 10.1124/jpet.117.242909. Epub 2017 Sep 7.
J Pharmacol Exp Ther. 2017.
PMID: 28882879
Item in Clipboard
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
Jurczak W, Elmusharaf N, Fox CP, Townsend W, Paulovich AG, Whiteaker JR, Krantz F, Wun CC, Parr G, Sharma S, Munugalavadla V, Manwani R, Dean E, Munir T.
Jurczak W, et al. Among authors: krantz f.
Ther Adv Hematol. 2023 May 30;14:20406207231173489. doi: 10.1177/20406207231173489. eCollection 2023.
Ther Adv Hematol. 2023.
PMID: 37273420
Free PMC article.
Item in Clipboard
Enhancing proteasomal processing improves survival for a peptide vaccine used to treat glioblastoma.
Fidanza M, Gupta P, Sayana A, Shanker V, Pahlke SM, Vu B, Krantz F, Azameera A, Wong N, Anne N, Xia Y, Rong J, Anne A, Skirboll S, Lim M, Wong AJ.
Fidanza M, et al. Among authors: krantz f.
Sci Transl Med. 2021 Jun 16;13(598):eaax4100. doi: 10.1126/scitranslmed.aax4100.
Sci Transl Med. 2021.
PMID: 34135109
Item in Clipboard
[Quantitative binding of ribonucleic acid with gallocyanin chrome alum].
SANDRITTER W, DIEFENBACH H, KRANTZ F.
SANDRITTER W, et al. Among authors: krantz f.
Experientia. 1954 May 15;10(5):210-2. doi: 10.1007/BF02159274.
Experientia. 1954.
PMID: 13173461
Undetermined Language.
No abstract available.
Item in Clipboard
Cite
Cite